Q&A with Alondra Nelson
By Misha Angrist,
Genome Magazine
| 03. 30. 2017
Why did you choose to examine African-Americans’ approach to genetic ancestry in The Social Life of DNA?
Given the Tuskegee syphilis experiment, given the history of eugenics, one of the curiosities for me was why in the world would African-Americans put their saliva in an envelope and expect that they’re going to get anything meaningful for their lives or their history [from a genetic ancestry] test? That became the puzzle of the book.
What did you learn?
That there were all sorts of complicated answers. The African-American genealogists I spoke with were not only suspicious, they were also curious — they were science geeks. I thought if they knew better, then they would do better. But what they said was, “Look, we know this history [of Tuskegee and eugenics] and we’re going into this with that history in mind, and we’ll take that into account as we negotiate and think about the results we get back.”
What does it mean for DNA to have a “social life?”
Initially, I thought I was talking about racial identity and ethnic identity. And...
Related Articles
By Emma McDonald Kennedy
| 10.29.2026
At the beginning of Nathan Fielder and Lance Oppenheim’s blockbuster documentary You Can See Everything, Billy Evans (partner of Theranos founder and convicted fraudster Elizabeth Holmes), says that they decided to do the film for one purpose: “radical transparency.” As they work on “Theranos 2.0,” Evans and Holmes want to show the public that she has been misunderstood –– painted as a liar and a fraud in the public imagination (and the courts) despite, as she claims in the...
By Jonquilyn Hill, Vox | 10.18.2026
By Roxanne Khamsi, The Atlantic | 10.16.2026
In recent months, news came out about several distressing cases that have underscored the risks of gene therapy, which delivers DNA to a patient’s cells to treat disease. All of these cases have one thing in common that’s not apparent...
By Rebecca Roberts, The Scientist | 10.11.2026
Heritable genome editing in human embryos is once again under intense scrutiny after the publication of an opinion piece in Trends in Genetics at the end of last month.1 In the paper, Cathy Tie, the founder and chief...